JP2013046615A5 - - Google Patents

Download PDF

Info

Publication number
JP2013046615A5
JP2013046615A5 JP2012196103A JP2012196103A JP2013046615A5 JP 2013046615 A5 JP2013046615 A5 JP 2013046615A5 JP 2012196103 A JP2012196103 A JP 2012196103A JP 2012196103 A JP2012196103 A JP 2012196103A JP 2013046615 A5 JP2013046615 A5 JP 2013046615A5
Authority
JP
Japan
Prior art keywords
seconds
sequence listing
teng
qiagen
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012196103A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013046615A (ja
Filing date
Publication date
Priority claimed from GBGB0127916.5A external-priority patent/GB0127916D0/en
Application filed filed Critical
Publication of JP2013046615A publication Critical patent/JP2013046615A/ja
Publication of JP2013046615A5 publication Critical patent/JP2013046615A5/ja
Pending legal-status Critical Current

Links

JP2012196103A 2001-11-21 2012-09-06 炎症性疾患治療用候補薬剤をスクリーニングするためのアッセイ Pending JP2013046615A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0127916.5A GB0127916D0 (en) 2001-11-21 2001-11-21 Method
GB0127916.5 2001-11-21

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2003547968A Division JP5362940B2 (ja) 2001-11-21 2002-11-20 炎症性疾患治療用候補薬剤をスクリーニングするためのアッセイ

Publications (2)

Publication Number Publication Date
JP2013046615A JP2013046615A (ja) 2013-03-07
JP2013046615A5 true JP2013046615A5 (enExample) 2014-09-04

Family

ID=9926193

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2003547968A Expired - Fee Related JP5362940B2 (ja) 2001-11-21 2002-11-20 炎症性疾患治療用候補薬剤をスクリーニングするためのアッセイ
JP2012196103A Pending JP2013046615A (ja) 2001-11-21 2012-09-06 炎症性疾患治療用候補薬剤をスクリーニングするためのアッセイ

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2003547968A Expired - Fee Related JP5362940B2 (ja) 2001-11-21 2002-11-20 炎症性疾患治療用候補薬剤をスクリーニングするためのアッセイ

Country Status (11)

Country Link
US (1) US7998474B2 (enExample)
EP (1) EP1448995B9 (enExample)
JP (2) JP5362940B2 (enExample)
AT (1) ATE496302T1 (enExample)
AU (1) AU2002343063B2 (enExample)
CA (1) CA2468082C (enExample)
DE (1) DE60239009D1 (enExample)
DK (1) DK1448995T3 (enExample)
ES (1) ES2362494T3 (enExample)
GB (1) GB0127916D0 (enExample)
WO (1) WO2003046580A1 (enExample)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20050390A1 (it) * 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
US7943328B1 (en) 2006-03-03 2011-05-17 Prometheus Laboratories Inc. Method and system for assisting in diagnosing irritable bowel syndrome
US20080085524A1 (en) * 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
US20100094560A1 (en) * 2006-08-15 2010-04-15 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
ES2473625T3 (es) * 2007-10-26 2014-07-07 Brenda E. Moore Composición probi�tica y métodos para inducir y mantener la pérdida de peso
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
EA020856B1 (ru) 2009-02-16 2015-02-27 Джулиани Интернэшнл Лимитед Способы лечения патологических состояний, связанных с волосами
US20140128276A1 (en) * 2011-01-13 2014-05-08 Oklahoma Medical Research Foundation Cytokine profiles as methods for diagnosis and prognosis of irritable bowel syndrome
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
US20130022575A1 (en) * 2011-07-19 2013-01-24 Microbial Rx Systems and methods of replacing intestinal flora
GB201117313D0 (en) * 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
DK2750682T3 (en) 2011-10-11 2016-08-22 Achim Biotherapeutics Ab A composition comprising anaerobically cultured human intestinal flora
JP6301844B2 (ja) 2012-02-09 2018-03-28 ノグラ ファーマ リミテッド 線維症の処置方法
EP2830599B1 (en) 2012-03-29 2018-08-15 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
EP2844242A1 (en) 2012-04-18 2015-03-11 Nogra Pharma Limited Methods of treating lactose intolerance
WO2013188529A1 (en) 2012-06-15 2013-12-19 Temple University Of The Commonwealth System Of Higher Education Use of isolated bacterial amyloids for treatment of inflammatory disorders or diseases of the epithelium
US9907755B2 (en) 2013-03-14 2018-03-06 Therabiome, Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
CN104546935A (zh) * 2014-09-30 2015-04-29 深圳华大基因科技有限公司 多形拟杆菌在治疗或预防类风湿性关节炎或其相关疾病中的应用
PE20171138A1 (es) 2014-12-23 2017-08-09 4D Pharma Res Ltd Modulacion inmunitaria
DK3193901T3 (en) 2014-12-23 2018-05-28 4D Pharma Res Ltd PIRIN POLYPEPTIDE AND IMMUNMODULATION
AU2018205072B2 (en) * 2014-12-23 2020-05-21 Cj Bioscience, Inc. Immune modulation
FR3035329A1 (fr) * 2015-04-23 2016-10-28 Agronomique Inst Nat Rech La prevention ou le traitement d'une infection par bacteroides thetaiotaomicron
EP3662917A1 (en) 2015-06-15 2020-06-10 4D Pharma Research Limited Compositions comprising bacterial strains
PE20180243A1 (es) 2015-06-15 2018-01-31 4D Pharma Res Ltd Composiciones que comprenden cepas bacterianas
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
LT3360559T (lt) 2015-06-15 2019-12-27 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
US20180088110A1 (en) * 2015-08-17 2018-03-29 Sekisui Medical Co., Ltd. Immunological detection method and test strip used therefor
MA41013A (fr) 2015-11-20 2017-08-30 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
MX373290B (es) 2016-03-04 2020-06-18 4D Pharma Plc Composiciones que comprenden cepas bacterianas.
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
TWI621708B (zh) * 2016-06-15 2018-04-21 ４Ｄ製藥研究有限公司 免疫調節
TWI782800B (zh) * 2016-06-15 2022-11-01 英商4D製藥研究有限公司 包含菌株之組合物及其用途、製法及產品
TWI750342B (zh) * 2016-06-15 2021-12-21 英商4D製藥研究有限公司 包含菌株之組合物及其用途、製法及產品
TWI802545B (zh) 2016-07-13 2023-05-21 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
MA48940A (fr) 2017-05-22 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
MA41708A (fr) 2017-05-24 2020-04-08 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
JP2020523326A (ja) 2017-06-14 2020-08-06 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物
PL3638271T3 (pl) 2017-06-14 2021-03-22 4D Pharma Research Limited Kompozycje zawierające szczepy bakteryjne
TWI767013B (zh) 2017-06-14 2022-06-11 英商4D製藥研究有限公司 包含細菌品系之組成物
MX2020007665A (es) 2018-01-19 2020-09-14 4D Pharma Res Limited Terapia de combinacion para tratar o prevenir el cancer.
JP2021516216A (ja) 2018-01-19 2021-07-01 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ がんを処置または予防するための併用療法
MX2020007681A (es) 2018-01-19 2020-09-14 4D Pharma Res Limited Terapia de combinacion para tratar o prevenir el cancer.
JP2021516662A (ja) 2018-01-19 2021-07-08 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ がんを処置または予防するための併用療法
WO2019180051A1 (en) 2018-03-19 2019-09-26 4D Pharma Research Limited Compositions comprising bacterial strains
LT3743086T (lt) 2018-05-11 2022-06-10 4D Pharma Research Limited Kompozicijos, apimančios bakterinius kamienus
AU2019287370A1 (en) 2018-06-14 2021-01-07 4D Pharma Research Ltd Compositions comprising bacterial strains
JP2021527639A (ja) 2018-06-19 2021-10-14 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 生物療法製品を含む剤形
EP3922256A1 (en) 2018-06-25 2021-12-15 4D Pharma Research Limited Compositions comprising bacterial strains
CN112566648A (zh) 2018-07-16 2021-03-26 4D制药研究有限公司 包含细菌菌株的组合物
TW202023590A (zh) 2018-08-17 2020-07-01 英商4D製藥研究有限公司 包含細菌菌株之組合物
US12144834B2 (en) 2018-09-13 2024-11-19 Xbiome Inc. Methods and compositions for treating gastrointestinal and inflammatory disorders
WO2020058499A1 (en) 2018-09-20 2020-03-26 4D Pharma Research Limited Compositions comprising bacterial strains
JP2022504185A (ja) * 2018-10-09 2022-01-13 フォーディー ファーマ リサーチ リミテッド 細菌株を含む組成物
JP2022504423A (ja) 2018-10-19 2022-01-13 フォーディー ファーマ リサーチ リミテッド 細菌株を含む組成物
TW202034949A (zh) 2018-11-02 2020-10-01 英商4D製藥研究有限公司 包含細菌菌株之組成物
AU2019396657A1 (en) 2018-12-12 2021-07-08 4D Pharma Research Limited Compositions comprising Parabacteroides bacterial strains for treating cancer
EP3893906A1 (en) 2018-12-12 2021-10-20 4D Pharma Research Limited Compositions comprising bacterial strains
WO2020120714A1 (en) 2018-12-12 2020-06-18 4D Pharma Research Limited Compositions comprising bacterial strains
EP3921299B1 (en) 2019-02-08 2024-11-20 Nogra Pharma Limited Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof
TW202108153A (zh) 2019-05-10 2021-03-01 英商4D製藥研究有限公司 包含細菌菌株之組成物
EP4066844A1 (en) 2019-07-05 2022-10-05 4D Pharma Research Limited Compositions comprising anaerostipes hadrus
WO2021098991A1 (en) 2019-11-20 2021-05-27 4D Pharma Research Limited Compositions comprising bacterial strains
EP3839039A1 (en) 2019-12-16 2021-06-23 4D Pharma Research Limited Providing bacterial biomass with improved storage stability
EP3838281A1 (en) 2019-12-20 2021-06-23 4D Pharma Research Limited Compositions comprising bacterial strains
TW202140773A (zh) 2020-01-27 2021-11-01 英商4D製藥研究有限公司 包含細菌菌株之組成物
TW202220639A (zh) 2020-08-06 2022-06-01 英商４Ｄ製藥有限公司 凍乾方法
CA3200126A1 (en) 2020-11-26 2022-06-02 Christophe Rene Leonard CARITE Process
JPWO2022191182A1 (enExample) * 2021-03-08 2022-09-15
AU2022391025A1 (en) * 2021-11-19 2024-06-06 The Brigham And Women's Hospital, Inc. Bifunctional chimeric molecules for labeling of kinases with target binding moieties and methods of use thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68928665T2 (de) 1988-08-02 1998-11-12 Gastro Services Pty Ltd Behandlung von gastro-intestinalen krankheiten
US5443826A (en) * 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
US5039703A (en) * 1989-11-16 1991-08-13 Breuer Richard I Method for treating inflammatory bowel disorders
US5599795A (en) * 1994-08-19 1997-02-04 Mccann; Michael Method for treatment of idiopathic inflammatory bowel disease (IIBD)
US6033864A (en) 1996-04-12 2000-03-07 The Regents Of The University Of California Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
GB9616047D0 (en) 1996-07-31 1996-09-11 Glaxo Group Ltd Medicament carrier with agglomerated large medicament particles and related method of manufacture thereof
WO1998043081A1 (en) 1997-03-26 1998-10-01 Ligand Pharmaceuticals Incorporated Treatment of gastrointestinal disease with ppar modulators
US5925657A (en) 1997-06-18 1999-07-20 The General Hospital Corporation Use of PPARγ agonists for inhibition of inflammatory cytokine production
US5951977A (en) * 1997-10-14 1999-09-14 The United States Of America, As Represented By The Secretary Of Agriculture Competitive exclusion culture for swine
WO2001016120A1 (en) 1999-08-27 2001-03-08 Eli Lilly And Company Biaryl-oxa(thia)zole derivatives and their use as ppars modulators
US6864355B1 (en) * 2000-05-02 2005-03-08 Yale University Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain
US20040062757A1 (en) * 2001-06-05 2004-04-01 Finegold Sydney M. Method of testing gastrointestinal diseases associated with species of genus clostridium
AUPQ899700A0 (en) * 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
CA2443935A1 (en) * 2001-04-18 2002-10-31 Merck & Co., Inc. Ppar-alpha-gamma ligands or agonists for the treatment of inflammation

Similar Documents

Publication Publication Date Title
Goldmeyer et al. Development of a novel one-tube isothermal reverse transcription thermophilic helicase-dependent amplification platform for rapid RNA detection
WO2015081229A3 (en) Selective amplification of nucleic acid sequences
JP2016195614A5 (enExample)
JP2010535480A5 (enExample)
UA118014C2 (uk) Спосіб модифікації днк-мішені
DE602005023588D1 (de) Verfahren zur genotypisierung von antigenen von blutzellen und ein kit zur genotypisierung
JP2014511692A5 (enExample)
Yang et al. Analysis on the complete genome of a novel caprine parainfluenza virus 3
JP2017521086A5 (enExample)
JP2010505434A5 (enExample)
CN103103270A (zh) 检测控制水稻耐盐等位基因的特异性pcr分子标记
KR20130111788A (ko) 고구마 바이러스 진단용 프라이머 쌍 및 이를 이용한 진단방법
JP2013515458A5 (enExample)
US7790876B2 (en) Sequences diagnostic for foot and mouth disease
JP2002504347A5 (enExample)
Thirulogachandar et al. An affinity-based genome walking method to find transgene integration loci in transgenic genome
JP2010136719A5 (enExample)
Macera et al. A novel rolling circle amplification assay to detect members of the family Anelloviridae in pigs and humans
El-Shehawi et al. Isolation and sequence analysis of wheat tissue-specific cDNAs by differential display
Chaves et al. Specific detection of minus strand hepatitis A virus RNA by Tail-PCR following reverse transcription
CN104480210B (zh) 鉴别曼地亚红豆杉幼苗的核苷酸序列、分子探针和方法
Sahr et al. Co-immunoprecipitation: Protein–RNA and Protein–DNA Interaction
CN103194443A (zh) 一种h9n2亚型禽流感病毒三个基因的多重逆转录扩增方法
Kim et al. Event-specific qualitative and quantitative detection of three genetically modified papaya events using a single standard reference molecule
Fan et al. Use of dual priming oligonucleotide system-based multiplex RT-PCR combined with high performance liquid chromatography assay for simultaneous detection of five enteric viruses associated with acute enteritis